GeneGo, Inc, a leading provider of databases, software and services in systems biology and chemistry, have integrated GenomeQuest’s Sequence Data Management (SDM) platform with GeneGo’s MetaCore and MetaDrug.

Using GenomeQuest’s interactive analysis, scientists who have drilled down to a list of particular genes of interest (hundreds of millions of reads, to thousands of expressed genes, to dozens or more of particular genes of interest) can now seamlessly pass that gene list along with their associated expression values (RPKM) to the GeneGo suite of pathway analysis software tools.

“The ability to analyze hundreds of datasets, reducing millions of reads down to a shorter list of particular genes of interest, and then being able to visualize where those genes are active in specific (potentially disease-related) pathways, is a significant accomplishment in the integration of omics software offerings. Scientists will be able to quickly focus on their scientific questions, rather than manipulating large reads datasets and lists of thousands of genes. We believe this will enhance discovery throughout the genomics and proteomics research pipelines,” said Dr Don Gregory, GenomeQuest’s director of Field Application Scientists.

“This integration will allow our joint customers to seamlessly work with NGS data in the context of pathways,” said Julie Bryant VP of business development for GeneGo. “The integrated workflows will lead our users from raw sequence runs to functional hypothesis generation of drug targets and biomarkers. With NGS data picking up steam in translational medicine and individual healthcare, this integration will help us to leverage our unique disease pathology maps (causal models) developed in our MetaMiner programmes in oncology, CNS, metabolic, respiratory diseases and other therapeutic areas.”